GlassScriptPhysician profile
Kristen Lambert
NPI 1306121454
$654.99
in general payments reported to CMS, 2019-2025
10 companies · $71.69 in 2025
The $71.69 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $78.90 · 2021: $43.37 · 2022: $78.34 · 2023: $112 · 2024: $127 · 2025: $71.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $129.85 | 2019-2025 | Wavelight Refractive Suite, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $99.07 | 2022-2024 | Infuse |
| Johnson & Johnson Vision Care, INC. | $90.81 | 2019-2025 | |
| Allergan, INC. | $88.48 | 2019 | |
| Oyster Point Pharma, INC. | $75.90 | 2023-2024 | Tyrvaya, Ryzumvi |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.11 | 2019-2020 | |
| Coopervision INC. | $37.62 | 2020-2021 | |
| Abbvie INC. | $33.84 | 2025 | |
| Astellas Pharma US INC | $22.45 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $20.86 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.